Sintx Technologies, Inc.
SINT Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$1.58
3.7%What Sintx Technologies, Inc. does
No business description yet.
- Legal name
- Sintx Technologies, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 20, 2026
- Accession ยท CIK
- 0001493152-26-011924
0001269026
Revenue and margins
Sintx Technologies, Inc. had $1.0M of revenue in fiscal 2025, down 64.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$8.8M in fiscal 2025, โ860.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Sintx Technologies, Inc. returned $0.1M to shareholders in fiscal 2025. The diluted share count rose 272.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Sintx Technologies, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Debt incl. finance leases | $1.0M | $0.5M | $0.0M | $0.0M | $0.0M |
| Debt / equity | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Current ratio | 5.5x | 0.9x | 1.9x | 2.3x | 1.5x |
| Quick ratio | 5.3x | 0.8x | 1.6x | 2.0x | 1.3x |
| Total assets | $21.8M | $15.8M | $15.4M | $9.4M | $9.5M |
| Total liabilities | $4.6M | $10.1M | $6.6M | $5.5M | $6.6M |
| Shareholders' equity | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Net debt (โ = net cash) | โ$13.3M | โ$5.7M | โ$3.3M | โ$3.6M | โ$4.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 3 / 9 | 2 / 8 | 2 / 8 | 3 / 9 | 3 / 9 | 4 / 9 | 5 / 9 | 4 / 9 | 3 / 9 |
| Accruals ratio | โ28.9% | โ22.7% | 5.3% | 15.9% | 10.5% | 3.1% | โ9.4% | 37.6% | โ19.2% | โ19.0% |
| Altman Z'' | โ27.90 | โ54.00 | โ67.09 | โ85.45 | โ16.53 | โ33.07 | โ58.84 | โ60.76 | โ105.09 | โ105.96 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $15.2M | $11.2M | $0.1M | $0.7M | $0.6M | $0.6M | $1.6M | $2.6M | $2.9M | $1.0M |
| Gross profit | $11.4M | $4.9M | $0.0M | $0.1M | $0.1M | $0.2M | $1.3M | $1.8M | $2.1M | $0.5M |
| Research and development | $6.3M | $3.5M | $3.0M | $3.4M | $4.8M | $5.9M | $6.5M | $8.7M | $5.2M | $4.6M |
| Operating income | โ$11.5M | โ$7.5M | โ$13.1M | โ$6.6M | โ$8.5M | โ$10.6M | โ$11.3M | โ$13.4M | โ$14.0M | โ$10.7M |
| Pretax income | โ$14.8M | โ$5.8M | โ$9.7M | โ$4.8M | โ$7.0M | โ$9.3M | โ$12.0M | โ$8.3M | โ$11.0M | โ$10.4M |
| Net income | โ$14.8M | โ$9.3M | โ$8.7M | โ$4.8M | โ$7.0M | โ$9.3M | โ$12.0M | โ$8.3M | โ$11.0M | โ$10.4M |
| Net income to common | โ$21.0M | โ$0.0M | โ$22.6M | โ$7.5M | โ$16.6M | โ$9.3M | โ$16.5M | โ$8.3M | โ$11.0M | โ$17.1M |
| Diluted EPS | โ$13.63 | โ$3.13 | โ$76.73 | โ$5.69 | โ$1.08 | โ$39.91 | โ$60.81 | โ$624.47 | โ$15.19 | โ$6.16 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | โ$7.2M | โ$4.7M | โ$9.3M | โ$6.4M | โ$9.1M | โ$10.1M | โ$10.3M | โ$14.1M | โ$8.6M | โ$8.6M |
| Capital expenditure | $0.7M | $0.0M | $0.0M | $0.1M | $0.4M | $3.7M | $1.4M | $0.5M | $0.7M | $0.2M |
| Free cash flow | โ$7.8M | โ$4.7M | โ$9.4M | โ$6.6M | โ$9.5M | โ$13.9M | โ$11.7M | โ$14.6M | โ$9.3M | โ$8.8M |
| Depreciation and amortization | $1.4M | $0.1M | $0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $0.9M | $0.8M | $0.3M |
| Stock-based compensation | $0.3M | $0.2M | $0.0M | $0.0M | $0.0M | $0.3M | $0.4M | $0.3M | $0.1M | $1.4M |
| Share buybacks | โ | โ | โ | โ | โ | โ | โ | โ | โ | $0.1M |
| Dividends and buybacks | โ | โ | โ | โ | โ | โ | โ | โ | โ | $0.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.9M | $0.5M | $5.4M | $1.8M | $25.4M | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Total debt | $7.0M | $3.0M | โ | $0.0M | $0.4M | $1.0M | $0.5M | $0.0M | $0.0M | $0.0M |
| Current assets | $16.0M | $3.7M | $7.0M | $4.1M | $27.6M | $15.0M | $7.2M | $5.5M | $4.5M | $5.7M |
| Current liabilities | $14.0M | $8.3M | $2.4M | $2.1M | $2.9M | $2.7M | $8.1M | $2.9M | $2.0M | $3.7M |
| Inventory | $7.2M | $0.7M | $0.7M | $0.6M | $0.5M | $0.6M | $0.7M | $0.9M | $0.5M | $0.8M |
| Property and equipment, net | $0.9M | $0.2M | $0.1M | $0.2M | $0.5M | $4.0M | $5.7M | $4.8M | $0.9M | $0.5M |
| Goodwill | $6.2M | $6.2M | โ | โ | โ | โ | โ | โ | โ | $0.3M |
| Intangible assets | $3.2M | $2.7M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M |
| Total assets | $26.3M | $14.6M | $11.5M | $9.1M | $30.4M | $21.8M | $15.8M | $15.4M | $9.4M | $9.5M |
| Total liabilities | $15.0M | $9.2M | $3.1M | $3.9M | $4.6M | $4.6M | $10.1M | $6.6M | $5.5M | $6.6M |
| Shareholders' equity | $11.2M | $5.4M | $8.4M | $5.2M | $25.8M | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Margins | ||||||||||
| Gross margin | 75.2% | 43.4% | 41.1% | 20.0% | 20.0% | 25.9% | 83.0% | 70.2% | 71.9% | 45.3% |
| Operating margin | โ75.8% | โ66.7% | โ13,806.3% | โ957.0% | โ1,431.6% | โ1,752.5% | โ726.1% | โ508.5% | โ486.6% | โ1,053.1% |
| EBITDA margin | โ66.3% | โ65.7% | โ13,695.8% | โ942.2% | โ1,418.5% | โ1,721.9% | โ704.7% | โ474.0% | โ457.4% | โ1,021.8% |
| Net margin | โ97.0% | โ83.1% | โ9,107.4% | โ696.2% | โ1,183.3% | โ1,536.1% | โ771.2% | โ314.4% | โ381.8% | โ1,018.1% |
| FCF margin | โ51.5% | โ41.7% | โ9,851.6% | โ955.3% | โ1,594.6% | โ2,288.9% | โ747.5% | โ557.5% | โ323.2% | โ860.1% |
| Returns | ||||||||||
| Return on capital | โ80.4% | โ75.2% | โ | โ151.5% | โ791.3% | โ212.9% | โ | โ192.6% | โ3,383.3% | โ |
| Return on capital employed | โ94.0% | โ117.5% | โ143.6% | โ93.1% | โ30.8% | โ55.6% | โ147.3% | โ107.2% | โ189.0% | โ185.7% |
| Return on equity | โ131.4% | โ111.9% | โ125.0% | โ70.5% | โ45.3% | โ43.3% | โ105.1% | โ114.1% | โ174.1% | โ303.8% |
| Return on assets | โ56.2% | โ45.6% | โ66.2% | โ46.4% | โ35.5% | โ35.6% | โ64.0% | โ53.0% | โ89.0% | โ109.6% |
| Return on tangible equity | โ1,116.2% | โ | โ270.0% | โ145.3% | โ64.4% | โ54.2% | โ290.4% | โ94.7% | โ284.3% | โ687.4% |
| Growth | ||||||||||
| Revenue growth | โ | โ26.3% | โ99.2% | 625.3% | โ13.8% | 2.0% | 157.6% | 68.3% | 9.9% | โ64.7% |
| Share count change | โ | 93.0% | โ87.1% | 305.3% | 1,021.2% | โ98.6% | 26.6% | โ93.1% | 3,316.5% | 272.4% |
| Financial health | ||||||||||
| Debt / equity | 0.6x | 0.5x | โ | 0.0x | 0.0x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.1x | 0.4x | 2.9x | 2.0x | 9.6x | 5.5x | 0.9x | 1.9x | 2.3x | 1.5x |
| Quick ratio | 0.6x | 0.4x | 2.7x | 1.7x | 9.4x | 5.3x | 0.8x | 1.6x | 2.0x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.4% | 0.1% | 11.6% | 21.3% | 60.6% | 617.8% | 90.0% | 20.2% | 23.9% | 18.2% |
| Stock comp / revenue | 1.8% | 2.0% | 44.2% | 0.3% | 7.6% | 51.0% | 23.6% | 11.1% | 2.8% | 136.5% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 3.0 | 2.0 | 2.0 | 3.0 | 3.0 | 4.0 | 5.0 | 4.0 | 3.0 |
| Altman Z'' | โ27.9 | โ54.0 | โ67.1 | โ85.5 | โ16.5 | โ33.1 | โ58.8 | โ60.8 | โ105.1 | โ106.0 |
| Accruals ratio | โ28.9% | โ22.7% | 5.3% | 15.9% | 10.5% | 3.1% | โ9.4% | 37.6% | โ19.2% | โ19.0% |
Source: SEC EDGAR XBRL filings (CIK 0001269026). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
